Replaces Prod. #: BML-PI114
Antibiotic. Inhibitor of aminopeptidase M, N and leucine and alanyl aminopeptidase and peptide deformylase (PDF). Inhibits MMP-1 (Ki=300nM), MMP-2 (IC50~90nM at MMP-2=5nM), MMP-3 (Ki=1’700nM), MMP-7 (IC50~3’500nM at MMP-7=19nM), MMP-8 (Ki=160nM), MMP-9 (Ki=330nM), MMP-10 (IC50~500nM at MMP-10=22nM), MMP-12 (IC50~350nM at MMP-12=4nM), and MMP-13 (IC50~100nM at MMP-13=13nM), but not MMP-14 (IC50>1mM at MMP-14=13.6nM). Shows antitumor activity in vitro and in vivo. Apoptosis inducer.
Product Details
| Alternative Name: | 3[[1-[[2-(Hydroxymethyl)-1-pyrrolidinyl]-carbonyl]-2-methylpropyl]-carbamoyl]-octanohydroxamic acid |
| |
| Formula: | C19H35N3O5 |
| |
| MW: | 385.5 |
| |
| Source: | Synthetic. |
| |
| CAS: | 13434-13-4 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | Soluble in 100% ethanol (20mg/ml) or DMSO (>20mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation: E.L. Orth-He, et al.; Cell Rep.
42, 111965 (2023),
Abstract;
Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis: H.Y. Imoto, et al.; Cell Rep.
38, 110444 (2022),
Abstract;
Parkin-independent mitophagy via Drp1-mediated outer membrane severing and inner membrane ubiquitination: Y. Oshima, et al.; J. Cell Biol.
220, 202006043 (2021),
Abstract;
Formyl-methionine as a degradation signal at the N-termini of bacterial proteins: K.I. Piatkov, et al. ; Microb. Cell
2, 376 (2015),
Application(s): Cell Culture,
Abstract;
Full Text
Actinonin induces apoptosis in U937 leukemia cells: M. Grujic, et al.; Cancer Lett.
223, 211 (2005),
Abstract;
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics: M.D. Lee, et al.; J. Clin. Invest.
114, 1107 (2004),
Abstract;
Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor: D.Z. Chen, et al.; Biochemistry
39, 1256 (2000),
Abstract;
Antitumor activity of actinonin in vitro and in vivo: Y. Xu, et al.; Clin. Cancer Res.
4, 171 (1998),
Abstract;
Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299: U. Lendeckel, et al.; BBRC
252, 5 (1998),
Abstract;
Effects of an antibiotic protease inhibitor, actinonin on the growth within collagen gels of non-metastatic and metastatic mouse mammary tumors of the same origin: K. Sayama, et al.; Cancer Lett
94, 171 (1995),
Abstract;
Gene expression, purification and characterization of recombinant human neutrophil collagenase: T.F. Ho, et al.; Gene
146, 297 (1994),
Abstract;
Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes: M. Hachisu, et al.; Life Sci.
41, 235 (1987),
Abstract;
Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes: H. Umezawa, et al.; J. Antibiot. (Tokyo)
38, 1629 (1985),
Abstract;
